- Home
- WELL vs MCK Comparison
WELL vs MCK Comparison
Compare WELL & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WELL | MCK |
|---|---|---|
| Founded | 1970 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Other Pharmaceuticals |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1B | 91.0B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | WELL | MCK |
|---|---|---|
| Price | $217.09 | $762.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 14 |
| Target Price | $224.38 | ★ $952.92 |
| AVG Volume (30 Days) | ★ 3.2M | 922.1K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.40% | 0.40% |
| EPS Growth | N/A | ★ 49.22 |
| EPS | 1.02 | ★ 38.38 |
| Revenue | $10,838,034,000.00 | ★ $112,084,000,000.00 |
| Revenue This Year | $28.56 | $14.94 |
| Revenue Next Year | $6.97 | $8.21 |
| P/E Ratio | $213.41 | ★ $19.90 |
| Revenue Growth | ★ 35.63 | 3.11 |
| 52 Week Low | $148.97 | $637.00 |
| 52 Week High | $221.68 | $999.00 |
Technical Indicators
Market Signals| Indicator | WELL | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 48.17 |
| Support Level | $210.23 | $727.64 |
| Resistance Level | $221.68 | $779.31 |
| Average True Range (ATR) | 6.17 | 16.44 |
| MACD | 0.93 | 0.71 |
| Stochastic Oscillator | 94.42 | 39.62 |
Price Performance
Historical ComparisonAbout WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,800 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
About MCK McKesson Corporation
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.